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1. Introduction 
S-Adenosyl-homocysteine (SAH) is one of the pro- 
ducts and the physiological inhibitor of S-adenosyl- 
methionine (SAM) mediated transmethylases [11. 
Sinefungin is an antifungal antibiotic isolated from 
cultures of Streptomyces griseolus [2,3]. The two 
molecules are closely related structurally, as Sinefungin 
differs from SAH only by the replacement of the sul- 
fur atom by a CH-NH2 group (fig. 1). Both compounds 
inhibit various methylation reactions in vitro [4] but 
only Sinefungin inhibits Rous sarcoma virus (RSV) 
induced foci formation, SAH being inactive [5,6]. As 
we have observed, an increase in the concentration of 
methylated bases of tRNA parallels the transformation 
of chick embryo fibroblasts (CEF) infected by RSV 
[7]. Thus, this work was undertaken in order to find 
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Fig.1. Structure of SAH and Sinefungin. 
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whether the two compounds have different effects on 
the methylation pattern of tRNA bases. Our results 
show that Sinefungin inhibits much stronger than 
SAH the monomethylation of guanine in position 2 
and 7 and of adenine in position 1 and 6, which may 
suggest a role for these methylations in the transfor- 
mation process. 
2. Materials and methods 
Cells, viruses and media were as in [ 51. For labelling 
experiments in whole cells, L-[methyl-14C]methionine 
(30-50 mCi/mM) was purchased from the Commis- 
sariat g 1’Energie Atomique, Saclay. The conditions 
were as in [ 71. tRNAs were extracted from a 12 000 X g 
supernatant of labelled cells. SAH and Sinefungin 
were added to the medium at 500 yM. 
The methylationofamixture ofE. coZiK12 tRNAs 
(supplied by Mr Escaut, ICSN, CNRS, Gif-sur-Yvette) 
in vitro was performed as in [ 71 with S-adenosyl 
L[methyZ-14C]methlonine (lo4 M) (45 mCi/mM) 
purchased from the same source. tRNAwas 0.5 mg/ml. 
To the incubation mixture were added 100 PM SAH 
and 30 PM Sinefungin, inhibiting by -50% the overall 
methylation of the tRNAs. 
In both cases, tRNAs were extracted by phenol- 
SDS and precipitated with ethanol. The quantity of 
tRNA was estimated by the orcinol method [8]. After 
hydrolysis in 80% formic acid at 170°C for 90 min, 
the methylated bases of tRNA were analyzed by bidi- 
mensional thin-layer chromatography on cellulose 
sheets (Eastman-Kodak) according to [9]. Standard 
methylated bases (Sigma, St Louis) were used as 
markers. 
Protein concentration was determined in cell 
extracts as in [lo] with crystalline bovine serum 
albumin as standard. 
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3. Results 
Table 1 shows the distribution of the methyl group 
incorporation in the different methylated bases in 
whole cells and in vitro. Results are expressed as % of 
the total radioactivity. 
3 .l. Effect of SAH andsinefungin on the methylation 
of tRNAs in normal and in RS V-transformed CEF 
The percent of inhibition of the methyl group 
incorporation in whole cells by 0.5 mM SAH and 
Sinefungin are shown in table 2. The values have been 
calculated from the radioactivity recovered from dif- 
ferent bases and are expressed in cpm/pg tRNA. 
The inhibition by both compounds is somewhat 
stronger in normal than in transformed cells. The effect 
of SAH is generally weaker than that of Sinefungin as 
the inhibition produced by the former ranges from 
20-40% in both cell types. Sinefungin has a more 
selective effect. The strongest inhibition is observed 
on the formation of m7G. The amounts of m2G, m’A 
and m6A are diminished by 48-54% in tRNAs of 
transformed cells. Furthermore the methyl group 
incorporation in m5C, m5U, m2G and m3C is weakly 
or not reduced at all by this molecule. 
3.2. Effect of SAH and Sinefungin on methylation of 
E. coli K-12 tRNA in vitro 
A mixture ofE. coli tRNA was methylated, respec- 
tively, by a normal and a RSV transformed cell-free 
extract to complete saturation. The same experiments 
Table 1 
Repartition of the methyl group incorporation in the 
different bases in whole cells and in vitro 
_ 
In whole cells In vitro 
Normal Transformed Normal Transformed 
cells cells cells cells 
mZG 16.4 11.9 53.2 51.4 
m:G 14.2 15.0 18.8 17.3 
m’G 8.9 8.2 4.0 2.0 
m*A 6.9 7.1 4.8 4.8 
m*A 0.1 0.1 0.6 0.3 
m6A 9.8 9.2 5.2 4.0 
m:A 0.5 0.2 0.6 0.3 
m5C 21.2 26.2 11.4 12.4 
m3C 4.1 4.0 0.4 0.3 
m5U 11.2 12.0 1.1 1.0 
Results are expressed in % of total radioactivity 
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Table2 
Effect of 0.5 mM SAH and Sinefungin on the methylation 
of tRNA in normal and RSV transformed CEI: 
_ 
Normal cells Transformed cells 
70 of inhibition 70 of inhibition by 
SAH Sinefungin SAW Sinefungin 
_____ 
m2G 38 62 22 48 
m:G 29 3 29 15 
m7G 42 95 23 94 
m’A 21 58 31 54 
m*A ~ .- _ _ 
m6A 36 58 11 49 
m:A 0 37 36 26 
mSC 32 14 24 0 
m3C 37 t2 31 0 
m5U 39 8 4 9 
___ 
Results are expressed as percent of inhibition of the methyl 
group incorporation in the different methylated bases. These 
values are calculated from 3 different experiments and the 
experimental error is estimated to i 10% 
under identical conditions were performed in the 
presence of either SAH or Sinefungin. The reaction 
was stopped after 120 min with buffer-saturated phenol. 
Table 3 shows the % of inhibition by SAH and 
Sinefungin of methyl group incorporation into tRNA 
Table 3 
Methylation of E coli K-l 2 tRNA by normal and RSV 
transformed CEI: extracts 
Normal cells Transformed cells 
70 of inhibition by % of inhibition by 
SAH Sinefunpin SAH Sinefungin 
mZG 26 78 10 84 
m:G 77 6 84 0 
m7G +18 73 +30 72 
m’A 56 85 58 86 
mZ A 33 66 50 67 
mbA 64 86 55 86 
m6,A 66 33 66 66 
m5C 61 31 52 47 
m3C 0 0 66 33 
mSU 50 50 55 55 
Results are given as percentage of inhibition of the methyl 
group incorporation in the presence of 100 FM and SAH and 
30 MM Sinefungin. The values are the means of 3 different 
experiments and the experimental error is estimated to * 10% 
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ofE. coti. The results obtained with heterologue tRNAs 
are similar to those observed in whole cells. Sinefungin 
inhibits much more strongly than SAH the m*G, 
m7G and mrA methyl transferases, while SAH but 
not Sinefungin is a very good inhibitor of m:G methyl 
transferase. The extent of inhibition by the two sub- 
stances is the same in the presence of the two different 
enzyme sources (normal and transformed cell-free 
extract). 
4. Discussion 
Most of the modified nucleosides have a specific 
location on the cloverleaf structure of tRNAs. In 
spite of the fact that the physiological role of these 
modified nucleosides is not yet fully understood, it 
seems that they confer to the tRNAs some structural 
c~iaracte~stics e sential for their function. Further- 
more their presence brings about structural differences 
between isoaccepting tRNAs and by this means they 
may play a role in the regulation of the function of 
tRNAs [I 1,125 
A several-fold increase in the activity of tRNA 
methyl transferases in neoplastic tissues as compared 
to normal ones has been observed [13,14]. We have 
described that an increase in the concentration of 
methylated bases of tRNA parallels the transforma- 
tion of CEF by RSV and also the fact that 5’-deoxy 
5’S_isobutyl thioadenosine (SIBA), an analogue which 
inhibits this increase, also inhibits cell transformation 
[7]. We showed also that SAH, the natural inhibitor 
of transmethylases doesnot affect cell transformation, 
whereas Sinefungin, a structurally closely related 
natural antibiotic, has very strong inhibitory effect on 
the same event [6]. The aim of this work was to com- 
pare the effect of the two compounds on tRNA 
methylation in whole cells and in vitro to understand 
whether their differential effect on cell transformation 
could be explained by their differential effect on 
tRNA-base methylation. The experiments show that 
Sinefun~n but not SAH inhibits very strongly the 
methylation of G in position 2 and 7 and that of A in 
position 1 ,and 6. The modified nucleoside m6A is 
generally found adjacent to the anticodon, for codons 
beginning with C and G. m’A is located in the T$C 
loop and m7G in the extra loop. m2G is a minor modi- 
fied base occurring only in tRNAs of eukaryotes. This 
base is located at the central part of the molecule 
which is involved in the interaction of tRNAs with the 
synthetases. According to Feldman’s theory the role 
of these minor bases is to make temporary covalent 
bonds through methylene bridges with some compo- 
nents of the translation apparatus [ 121. Further stud- 
ies are needed to conclude in favour of a decisive role 
in the tr~sforl~ation process for the methylation of 
these four bases of tRNA. 
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